330 related articles for article (PubMed ID: 29521246)
21. A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.
Wang N; Chen Y; Ren B; Xiang Y; Zhao N; Zhan X; Feng B
BMC Health Serv Res; 2022 Mar; 22(1):318. PubMed ID: 35260158
[TBL] [Abstract][Full Text] [Related]
22. Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
Suyagh M; Farah D; Abu Farha R
Saudi Pharm J; 2015 Apr; 23(2):147-53. PubMed ID: 25972734
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia.
Abdulsalim S; Farooqui M; Alshammari MS; Alotaibi M; Alhazmi A; Alqasomi A; Altowayan WM
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834240
[TBL] [Abstract][Full Text] [Related]
24. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
Hariraj V; Aziz Z
Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
[TBL] [Abstract][Full Text] [Related]
25. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
[TBL] [Abstract][Full Text] [Related]
26. Knowledge, attitude and practice towards pharmacovigilance and reporting of adverse drug reactions among health care professionals in Albania: A cross-sectional study.
Shkreli R; Dhamo K; Haloçi E; Tabaku A
Pak J Pharm Sci; 2023 May; 36(3):713-721. PubMed ID: 37580918
[TBL] [Abstract][Full Text] [Related]
27. Healthcare professionals' knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia.
Seid MA; Kasahun AE; Mante BM; Gebremariam SN
Int J Clin Pharm; 2018 Aug; 40(4):895-902. PubMed ID: 30094559
[TBL] [Abstract][Full Text] [Related]
28. A survey on the knowledge, attitudes and practices of physicians towards pharmacovigilance in Jordanian health centres.
Shroukh WA; Shakhatreh FM; Yasein NA; Sharkas GF
Int Health; 2018 Sep; 10(5):363-370. PubMed ID: 29718320
[TBL] [Abstract][Full Text] [Related]
29. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis.
Terblanche A; Meyer JC; Godman B; Summers RS
Hosp Pract (1995); 2017 Dec; 45(5):238-245. PubMed ID: 28914115
[TBL] [Abstract][Full Text] [Related]
30. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
32. Reporting, handling, and subjective importance of adverse drug reactions among general practitioners: an exploratory cross-sectional survey.
Gahr M; Connemann B; Zeiss R; Schönfeldt-Lecuona C; Dreyhaupt J; Lazik C
Expert Opin Drug Saf; 2021 Aug; 20(8):979-985. PubMed ID: 34014779
[No Abstract] [Full Text] [Related]
33. Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey.
Khardali A
Sci Rep; 2024 Feb; 14(1):4819. PubMed ID: 38413787
[TBL] [Abstract][Full Text] [Related]
34. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
[No Abstract] [Full Text] [Related]
35. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
Adenuga BA; Kibuule D; Rennie TW
Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
[TBL] [Abstract][Full Text] [Related]
36. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital.
Ergün Y; Ergün TB; Toker E; Ünal E; Akben M
Int Health; 2019 May; 11(3):177-184. PubMed ID: 30265317
[TBL] [Abstract][Full Text] [Related]
37. Knowledge, attitude, and practice regarding pharmacovigilance among the general public in Western China: a cross-sectional study.
Chen Y; Wang Y; Wang N; Xiang Y; Zhang R; Xiao J; Liu H; Feng B
Curr Med Res Opin; 2021 Jan; 37(1):101-108. PubMed ID: 33136523
[TBL] [Abstract][Full Text] [Related]
38. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
Mulchandani R; Kakkar AK
Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
[TBL] [Abstract][Full Text] [Related]
39. Parental reporting of adverse drug reactions in South Africa: An online survey.
Pillay S; Mulubwa M; Viljoen M
Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e8. PubMed ID: 34636609
[TBL] [Abstract][Full Text] [Related]
40. [The general practitioner's knowledge and attitude towards proton pump inhibitors adverse effects].
Rudelle K; Laroche ML
Therapie; 2020; 75(3):253-260. PubMed ID: 31471066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
